Roberto Cammarata

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Damiano D. Caputo · 10 shared papers, 2022–2026 · strength 2.30
   • Paper Plasma Protein Corona Fingerprinting Across Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers18203275↗
   • Paper Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. DOI 10.3390/cancers17183085↗
   • Paper Pancreatic Steatosis as a Risk Phenotype for Pancreatic Ductal Adenocarcinoma: A Narrative Review. DOI 10.3390/medicina62040729↗
2. Vincenzo La Vaccara · 8 shared papers, 2022–2026 · strength 1.92
   • Paper Plasma Protein Corona Fingerprinting Across Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers18203275↗
   • Paper Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. DOI 10.3390/cancers17183085↗
   • Paper Pancreatic Steatosis as a Risk Phenotype for Pancreatic Ductal Adenocarcinoma: A Narrative Review. DOI 10.3390/medicina62040729↗
3. Roberto Coppola · 8 shared papers, 2022–2026 · strength 1.86
   • Paper Plasma Protein Corona Fingerprinting Across Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers18203275↗
   • Paper Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma: Aligning Guideline Recommendations with Real-World Evidence. DOI 10.3390/cancers17183085↗
   • Paper Pancreatic Steatosis as a Risk Phenotype for Pancreatic Ductal Adenocarcinoma: A Narrative Review. DOI 10.3390/medicina62040729↗
4. Alessandro Coppola · 5 shared papers, 2022–2023 · strength 0.88
   • Paper Role of Neoplastic Markers in Pancreatic Adenocarcinoma. DOI 10.3390/jcm11216509↗
   • Paper Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for … PMID 36810297↗
   • Paper Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going. DOI 10.3390/jcm12113677↗
5. Sara Elsa Aita · 2 shared papers, 2026 · strength 0.62
   • Paper Plasma Protein Corona Fingerprinting Across Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers18203275↗
   • Paper Pancreatic Steatosis as a Risk Phenotype for Pancreatic Ductal Adenocarcinoma: A Narrative Review. DOI 10.3390/medicina62040729↗
6. Erica Quagliarini · 3 shared papers, 2022–2025 · strength 0.61
   • Paper Coupling magnetic levitation of graphene oxide–protein complexes with blood levels of glucose for early detection of pa… DOI 10.1186/s12645-023-00170-1↗
   • Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d↗
   • Paper Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Ph… DOI 10.3390/cancers14194658↗
7. Giulio Caracciolo · 3 shared papers, 2022–2025 · strength 0.61
   • Paper Coupling magnetic levitation of graphene oxide–protein complexes with blood levels of glucose for early detection of pa… DOI 10.1186/s12645-023-00170-1↗
   • Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d↗
   • Paper Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Ph… DOI 10.3390/cancers14194658↗
8. Daniela Pozzi · 3 shared papers, 2022–2025 · strength 0.61
   • Paper Coupling magnetic levitation of graphene oxide–protein complexes with blood levels of glucose for early detection of pa… DOI 10.1186/s12645-023-00170-1↗
   • Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d↗
   • Paper Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Ph… DOI 10.3390/cancers14194658↗
9. Luca Digiacomo · 2 shared papers, 2022–2025 · strength 0.37
   • Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d↗
   • Paper Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Ph… DOI 10.3390/cancers14194658↗
10. Heinz Wilfried Amenitsch · 1 shared paper, 2025 · strength 0.23
    • Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d↗
11. Francesco Giovinazzo · 1 shared paper, 2023 · strength 0.18
    • Paper Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going. DOI 10.3390/jcm12113677↗
12. Sara Ramella · 1 shared paper, 2022 · strength 0.16
    • Paper Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. DOI 10.3390/biomedicines10092091↗
13. Michele Fiore · 1 shared paper, 2022 · strength 0.16
    • Paper Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. DOI 10.3390/biomedicines10092091↗
14. Riccardo Di Santo · 1 shared paper, 2022 · strength 0.14
    • Paper Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Ph… DOI 10.3390/cancers14194658↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.